OHBM 2025 – ZenoWell Presents Breakthrough Research on taVNS and Brain Modulation
Date: June 23–27, 2025
Location: Brisbane Convention & Exhibition Centre, Brisbane, Australia
At the Annual Meeting of the Organization for Human Brain Mapping (OHBM) 2025, held from June 23 to 27 in Brisbane, Australia, ZenoWell’s co-founder Dr. Shaw joined the global neuroscience community to explore cutting-edge advancements in human brain research.
ZenoWell presented two original studies at this prestigious conference, showcasing the company’s commitment to scientific rigor and clinical validation of transcutaneous auricular vagus nerve stimulation (taVNS):
-
🧠 “Reproducibility of HRV as a Biomarker for Transcutaneous Auricular Vagus Nerve Stimulation” This study examined the reliability and consistency of heart rate variability (HRV) as a physiological biomarker for taVNS interventions. The findings contribute valuable insights toward establishing HRV as a robust and measurable endpoint in neuromodulation research.
-
🧘♀️ “Alpha Modulation by Personalized TaVNS and Meditation: A High-Density EEG Exploration” Combining closed-loop, respiration-gated taVNS with meditation, this research used high-density EEG to investigate how personalized stimulation protocols can enhance alpha brainwave activity, supporting deeper and more effective meditative states.
Both studies sparked active discussion among researchers from Australia, Europe, North America, Japan, mainland China, and Taiwan, reflecting a growing international interest in the intersection of vagus nerve stimulation, brain science, and mental well-being.
ZenoWell’s presence at OHBM 2025 reinforced its role not only as a healthtech innovator, but also as a scientific contributor to the evolving field of non-invasive neuromodulation.
Article précédent
IFA 2025 – ZenoWell to Unveil the Future of Wearable Neurotech in Berlin
Prochain article
CES 2025 – ZenoWell Showcases the Future of Wearable Neurotechnology
Related Posts
ICP 2024 – ZenoWell cofounder Presents Breakthrough Research on ASD and Neuroimaging
Date: July 21 – 26, 2024 Location: O₂ universum，Prague, Czech Republic At the 33rd International Congress of Psychology (ICP 2024), held once every four...
Jul 30 2025
CES 2025 – ZenoWell Showcases the Future of Wearable Neurotechnology
Date: January 9–12, 2025 Location: Digital Health Pavilion, CES, Las Vegas Convention Center, Las Vegas, USA ZenoWell made its official debut at CES 2025,...
Jul 25 2025
IFA 2025 – ZenoWell to Unveil the Future of Wearable Neurotech in Berlin
Date: September 5–9, 2025 Location: Messe Berlin, Berlin, Germany Exhibition Area: IFA Health & Wellness Tech Pavilion Registration Link: https://ifa-berlin-2025.reg.buzz/ ZenoWell is excited to...
Jul 25 2025
CES 2026 – ZenoWell Returns to Las Vegas with Cutting-Edge taVNS Innovations
Date: January 6–9, 2026 Location: Las Vegas Convention Center, Las Vegas, USA Exhibition Area: Digital Health Pavilion Award Entry: CES Innovation Award 2026 –...
Jul 25 2025
DGPPN Congress 2025 – ZenoWell to Present Vita & Luna at Europe’s Leading Psychiatry Conference
Date: November 26–29, 2025 Location: CityCube Berlin, Berlin, Germany Exhibition Area: DGPPN Industry Exhibition, Mental Health Technology Section Registration Link: https://www.dgppnkongress.de/ ZenoWell is honored...
Jul 25 2025
Gastroparesis Awareness Month 2025 – ZenoWell Partners with G-PACT to Promote GI Health Education
Date: August 1–31, 2025 Location: Online + Community Outreach (USA) Partner: G-PACT (Gastroparesis Patient Association for Cures and Treatments) Partner link: https://www.g-pact.org/ In recognition...
Jul 25 2025
